A subset analysis of clinical activity and pharmacodynamic biomarkers in patients with sarcomas in the phase 1 dose-escalation study of STC-15, a METTL3 inhibitor.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Justin C. Moser, Jordi Rodon Ahnert, Kyriakos Papadopoulos, Yaara Ofir-Rosenfeld, Josefin-Beate Holz, Melinda Snyder, Marguerite Hutchinson, Kristen McCaleb, Sean Uryu, Ayush Raman, Ananya Anmangandla, Gudrun Stengel, Eric Martin
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162497547
Cites:
Cited by:
Related to: